A Single-Institute Experience with C-ros Oncogene 1 Translocation in Non-Small Cell Lung Cancers in Taiwan

(1) Background: The C-ros oncogene 1 (ROS1) gene translocation is an important biomarker for selecting patients for crizotinib-targeted therapy. The aim of this study was to understand the incidence, diagnostic algorithm, clinical course and objective response to crizotinib in ROS1 translocated lung...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hsiang-Sheng, Liu, Chien-Ying, Hsu, Sheng-Chi, Huang, Shih-Chiang, Hung, Tsai-Hsien, Ng, Kwai-Fong, Chen, Tse-Ching
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145855/
https://www.ncbi.nlm.nih.gov/pubmed/35628598
http://dx.doi.org/10.3390/ijms23105789

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145855/
https://www.ncbi.nlm.nih.gov/pubmed/35628598
http://dx.doi.org/10.3390/ijms23105789

Ejemplares similares